VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 93 filers reported holding VERVE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,600,071 | -4.7% | 120,669 | +34.8% | 0.00% | 0.0% |
| Q2 2023 | $1,678,931 | -76.4% | 89,543 | -81.9% | 0.00% | -80.0% |
| Q1 2023 | $7,123,754 | +122.2% | 494,019 | +198.2% | 0.01% | +66.7% |
| Q4 2022 | $3,205,889 | -44.4% | 165,679 | -1.2% | 0.00% | -25.0% |
| Q3 2022 | $5,761,000 | +4472.2% | 167,720 | +1933.5% | 0.00% | – |
| Q2 2022 | $126,000 | -85.7% | 8,248 | -78.7% | 0.00% | -100.0% |
| Q1 2022 | $882,000 | -80.3% | 38,672 | -68.1% | 0.00% | -50.0% |
| Q4 2021 | $4,467,000 | +5155.3% | 121,157 | +6579.0% | 0.00% | – |
| Q3 2021 | $85,000 | – | 1,814 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |